BSX Q4 2020 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$105B

Q4 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$2.7B-6.8% YoY

Gross Profit

$1.5B55.4% margin

Operating Income

$174M6.4% margin

Net Income

$152M5.6% margin

EPS (Diluted)

$0.10

QoQ Revenue Growth

+1.8%

Cash Flow

Operating Cash Flow

$673M

Free Cash Flow

$514M

Stock-Based Comp.

$42M

Balance Sheet

Total Assets

$30.8B

Total Liabilities

$15.5B

Stockholders' Equity

$15.3B

Cash & Equivalents

$1.7B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.7B	$2.9B	-6.8%
Gross Profit	$1.5B	$1.8B	-17.8%
Operating Income	$174M	$409M	-57.5%
Net Income	$152M	$4.0B	-96.2%

Revenue Segments

Cardiovascular

$1.0B53%

MedSurg

$891M47%

Geographic Segments

UNITED STATES

$1.5B57%

Non-US

$1.2B43%